A series of telodendrimer (a linear
polyethyelene glycol-block-dendritic oligo-cholic
acid) have been synthesized
via a bottom-up approach to optimize the hemocompatibility of the
nanocarrier. Numbers of hydrophilic glycerol groups were introduced
onto the polar surface of cholic acid to reduce the plasma membrane
lytic activity of telodendrimers. An interesting result was observed:
only an optimum number of glycerol introduced could reduce the hemolytic
properties of the nanocarrier; on the contrary, more glycerols or
the amino-glycerol substitution onto cholic acid significantly increased
the hemolytic properties of the nanocarriers. To further elucidate
the structure–property relationship, the molecular dynamic
approach was used to simulate the conformation of the subunits of
telodendrimers with different glycerol substitution, and the binding
energies and the polar surface areas of the hairpin conformations
were calculated to explain the membrane activities of nanocarriers.
In addition, these telodendrimer subunits were synthesized and their
membrane activities were tested directly, which validated the computational
prediction and correlated with the observed hemolytic activity of
nanocarriers. The glycerol substitution sustained the facial amphiphilicity
of cholic acid, maintaining the superior drug loading capacity (paclitaxel
and doxorubicin), stability, cell uptake, and anticancer efficacy
of payloads. The in vivo optical imaging study indicated that the
optimized nanocarriers can specifically deliver drug molecules to
the tumor sites more efficiently than free drug administration, which
is essential for the enhanced cancer treatment.